# Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

> **NCT01175148** · PHASE2 · COMPLETED · sponsor: **West Virginia University** · enrollment: 60 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Atorvastatin calcium (Lipitor)

## Key facts

- **NCT ID:** NCT01175148
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175148, "Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01175148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*